title: [Frequency of persistent or transitory serologic negative values in infants with congenital toxoplasmosis. Experience of the Reims Toxoplasmosis Group (1980-1997)].
authors.forename: C
authors.initials: C
authors.lastname: Chemla
authors.forename: I
authors.initials: I
authors.lastname: Villena
authors.forename: D
authors.initials: D
authors.lastname: Aubert
authors.forename: B
authors.initials: B
authors.lastname: Leroux
authors.forename: D
authors.initials: D
authors.lastname: Dupouy
authors.forename: J M
authors.initials: JM
authors.lastname: Pinon
mesh_terms: D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood*; D004338:Drug Combinations; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011739:Pyrimethamine / Q000627:therapeutic use; D015572:Spiramycin / Q000627:therapeutic use; D013413:Sulfadoxine / Q000627:therapeutic use; D014122:Toxoplasma / Q000276:immunology*; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy / Q000276:immunology*
chemical_list: D000913:Antibodies, Protozoan; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D015572:Spiramycin; D013413:Sulfadoxine; D011739:Pyrimethamine